skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Refinado por: tipo de recurso: Newsletter Articles remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Mesoblast, Inc.; Researchers Submit Patent Application, "Expansion of Haemopoietic Precursors", for Approval
Mesoblast, Inc.; Researchers Submit Patent Application, "Expansion of Haemopoietic Precursors", for Approval
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Mesoblast, Inc.; Researchers Submit Patent Application, "Expansion of Haemopoietic Precursors", for Approval

Politics & Government Week, 2015, p.8844

Atlanta: NewsRx

Texto completo disponível

Citações Citado por
2
Researcher at University of Oklahoma Details Research in Acute Lymphoblastic Leukemia
Researcher at University of Oklahoma Details Research in Acute Lymphoblastic Leukemia
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Researcher at University of Oklahoma Details Research in Acute Lymphoblastic Leukemia

Hematology Week, 2023, p.694

NewsRX LLC

Texto completo disponível

Citações Citado por
3
Investigators from Duke University Have Reported New Data on Graft-Versus-Host Disease (A Phase I Trial of Syk Inhibition With Fostamatinib In the Prevention and Treatment of Chronic Graft-versus-host Disease)
Investigators from Duke University Have Reported New Data on Graft-Versus-Host Disease (A Phase I Trial of Syk Inhibition With Fostamatinib In the Prevention and Treatment of Chronic Graft-versus-host Disease)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Investigators from Duke University Have Reported New Data on Graft-Versus-Host Disease (A Phase I Trial of Syk Inhibition With Fostamatinib In the Prevention and Treatment of Chronic Graft-versus-host Disease)

Health & Medicine Week, 2023, p.2456

NewsRX LLC

Texto completo disponível

Citações Citado por
4
Recent Findings from Institute Gustave Roussy Provides New Insights into Acute Myeloid Leukemia (Targeting Rara Overexpression With Tamibarotene, a Potent and Selective Rar Alpha Agonist, Is a Novel Approach In Aml)
Recent Findings from Institute Gustave Roussy Provides New Insights into Acute Myeloid Leukemia (Targeting Rara Overexpression With Tamibarotene, a Potent and Selective Rar Alpha Agonist, Is a Novel Approach In Aml)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Recent Findings from Institute Gustave Roussy Provides New Insights into Acute Myeloid Leukemia (Targeting Rara Overexpression With Tamibarotene, a Potent and Selective Rar Alpha Agonist, Is a Novel Approach In Aml)

Hematology Week, 2023, p.3551

NewsRX LLC

Texto completo disponível

Citações Citado por
5
University Hospital Reports Findings in Antineoplastics
University Hospital Reports Findings in Antineoplastics
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

University Hospital Reports Findings in Antineoplastics

Chemicals & Chemistry, 2022, p.3144

NewsRX LLC

Texto completo disponível

Citações Citado por
6
Reports from Chinese People's Liberation Army
Reports from Chinese People's Liberation Army
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Reports from Chinese People's Liberation Army

Hematology Week, 2023, p.3710

NewsRX LLC

Texto completo disponível

Citações Citado por
7
Study Data from Duke University Medical Center Provide New Insights into Delirium (Clinical and Neuroimaging Correlates of Post-transplant Delirium)
Study Data from Duke University Medical Center Provide New Insights into Delirium (Clinical and Neuroimaging Correlates of Post-transplant Delirium)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Study Data from Duke University Medical Center Provide New Insights into Delirium (Clinical and Neuroimaging Correlates of Post-transplant Delirium)

Mental Health Weekly Digest, 2021, p.429

NewsRX LLC

Texto completo disponível

Citações Citado por
8
Researchers from State University Maringa Report Findings in Mycobacteria
Researchers from State University Maringa Report Findings in Mycobacteria
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Researchers from State University Maringa Report Findings in Mycobacteria

Health & Medicine Week, 2024

NewsRX LLC

Texto completo disponível

Citações Citado por
9
MESOBLAST, INC.; Patent Issued for Expansion of Haemopoietic Precursors (USPTO 9415072)
MESOBLAST, INC.; Patent Issued for Expansion of Haemopoietic Precursors (USPTO 9415072)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

MESOBLAST, INC.; Patent Issued for Expansion of Haemopoietic Precursors (USPTO 9415072)

Journal of Engineering, 2016, p.3724

Atlanta: NewsRx

Texto completo disponível

Citações Citado por
10
Recent Research from Duke University Highlight Findings in Sepsis (Chlorhexidine Gluconate Bathing Reduces the Incidence of Bloodstream Infections In Adults Undergoing Inpatient Hematopoietic Cell Transplantation)
Recent Research from Duke University Highlight Findings in Sepsis (Chlorhexidine Gluconate Bathing Reduces the Incidence of Bloodstream Infections In Adults Undergoing Inpatient Hematopoietic Cell Transplantation)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Recent Research from Duke University Highlight Findings in Sepsis (Chlorhexidine Gluconate Bathing Reduces the Incidence of Bloodstream Infections In Adults Undergoing Inpatient Hematopoietic Cell Transplantation)

Hematology Week, 2021, p.711

NewsRX LLC

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2014  (7)
  2. 2014Até2015  (22)
  3. 2016Até2017  (4)
  4. 2018Até2020  (9)
  5. Após 2020  (13)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.